A drug used to treat erectile dysfunction, is showing promise for patients suffering from a rare blood condition. Raynaud’s disease is a condition that causes discoloration of fingers and toes. When people with Raynaud’s disease are exposed to the cold, their blood vessels close causing their fingers or toes to turn white or red. Some doctors believe
The Hackensack NJ Support Group of the Tri-State Scleroderma Foundation is sponsoring an Autoimmune Disease Patient Education Panel
Good news for fellow Frosties with Lupus! HEALTH INDUSTRY MARCH 9, 2011, 6:22 P.M. ET Wall Street Journal The Food and Drug Administration approved a new lupus drug from Human Genome Sciences Inc. and GlaxoSmithKline PLC, marking the first new treatment for the autoimmune disease in more than 50 years.
Modified-Release Therapy is Well Tolerated in Clinical Trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor
Sound Familiar??? http://www.cnn.com/2011/HEALTH/03/02/thermostat.arguments/